• Home
  • Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.

Author List
Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P, KEYNOTE-355 Investigators
Publication
The New England journal of medicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/316673124
Publication Year
2022
PubMed ID
35857659
Publication Title
Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P, KEYNOTE-355 Investigators. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer. N Engl J Med. 2022 07 21; 387(3):217-226.